The FDA has requested Moderna and Pfizer-BioNTech to expand the age range of boys and young men at risk for…
Browsing: Pfizer
The Success Story of Mirdametinib: A Lesson in Rescuing Shelved Pharma Assets Once destined for Pfizer’s R&D junk pile, the…
Pfizer Halts Development of Obesity Pill Due to Liver Injury Concerns Pfizer has made the decision to discontinue the development…
Dr. Mikael Dolsten, the former chief scientific officer and president of R&D at Pfizer, has been a prominent figure in…
Patrizia Cavazzoni, a highly respected former official at the Food and Drug Administration (FDA), has recently been appointed as the…